{"id":"https://openalex.org/W4293204477","doi":"https://doi.org/10.47895/amp.vi0.4183","title":"Efficacy and Safety of Interferon in the Treatment of Patients with COVID-19: A Systematic Review and Meta-analysis","display_name":"Efficacy and Safety of Interferon in the Treatment of Patients with COVID-19: A Systematic Review and Meta-analysis","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4293204477","doi":"https://doi.org/10.47895/amp.vi0.4183"},"language":"en","primary_location":{"id":"doi:10.47895/amp.vi0.4183","doi":"https://doi.org/10.47895/amp.vi0.4183","is_oa":true,"landing_page_url":"https://doi.org/10.47895/amp.vi0.4183","pdf_url":null,"source":{"id":"https://openalex.org/S4306500404","display_name":"Acta Medica Philippina","issn_l":"0001-6071","issn":["0001-6071","2094-9278"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319568","host_organization_name":"University of the Philippines Manila","host_organization_lineage":["https://openalex.org/P4310319568","https://openalex.org/P4310319558"],"host_organization_lineage_names":["University of the Philippines Manila","University of the Philippines"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Medica Philippina","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.47895/amp.vi0.4183","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112752487","display_name":"Eva I. Bautista","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Bautista","raw_affiliation_strings":["FEU-NRMF"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FEU-NRMF","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049989359","display_name":"Gina Antonina S. Eubanas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gina Antonina Eubanas","raw_affiliation_strings":["Institute of Clinical Epidemiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Epidemiology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062319946","display_name":"Dan Louie Renz P. Tating","orcid":"https://orcid.org/0000-0001-8121-2774","observed_orcids":["https://orcid.org/0000-0001-8121-2774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dan Louie Renz Tating","raw_affiliation_strings":["Institute of Clinical Epidemiology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Epidemiology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.6850000023841858},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8999999761581421},{"id":"https://openalex.org/keywords/lopinavir","display_name":"lopinavir","score":0.8320000171661377},{"id":"https://openalex.org/keywords/interferon-combination-therapy","display_name":"interferon combination therapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7319999933242798},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.5809999704360962},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5049999952316284},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.39100000262260437},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.7200000286102295},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.656000018119812},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.7490000128746033},{"id":"https://openalex.org/keywords/glucocorticoids","display_name":"glucocorticoids","score":0.7459999918937683},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cytokine-storm","display_name":"cytokine storm","score":0.4690000116825104},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.5559999942779541},{"id":"https://openalex.org/keywords/sars-cov","display_name":"SARS-CoV","score":0.4300000071525574},{"id":"https://openalex.org/keywords/mers-cov","display_name":"MERS-CoV","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8499823808670044},{"id":"https://openalex.org/C2776348555","wikidata":"https://www.wikidata.org/wiki/Q344873","display_name":"ARDS","level":3,"score":0.7851943969726562},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6729377508163452},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6093016862869263},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5571058392524719},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.5185940265655518},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.46820738911628723},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4220593273639679},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.41934627294540405},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27109959721565247},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.14352017641067505},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.47895/amp.vi0.4183","doi":"https://doi.org/10.47895/amp.vi0.4183","is_oa":true,"landing_page_url":"https://doi.org/10.47895/amp.vi0.4183","pdf_url":null,"source":{"id":"https://openalex.org/S4306500404","display_name":"Acta Medica Philippina","issn_l":"0001-6071","issn":["0001-6071","2094-9278"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319568","host_organization_name":"University of the Philippines Manila","host_organization_lineage":["https://openalex.org/P4310319568","https://openalex.org/P4310319558"],"host_organization_lineage_names":["University of the Philippines Manila","University of the Philippines"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Medica Philippina","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.47895/amp.vi0.4183","doi":"https://doi.org/10.47895/amp.vi0.4183","is_oa":true,"landing_page_url":"https://doi.org/10.47895/amp.vi0.4183","pdf_url":null,"source":{"id":"https://openalex.org/S4306500404","display_name":"Acta Medica Philippina","issn_l":"0001-6071","issn":["0001-6071","2094-9278"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319568","host_organization_name":"University of the Philippines Manila","host_organization_lineage":["https://openalex.org/P4310319568","https://openalex.org/P4310319558"],"host_organization_lineage_names":["University of the Philippines Manila","University of the Philippines"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Medica Philippina","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361292565","https://openalex.org/W3133131390","https://openalex.org/W3176297990","https://openalex.org/W3167333391","https://openalex.org/W3212484596","https://openalex.org/W3205443024","https://openalex.org/W3167213065","https://openalex.org/W3202824108","https://openalex.org/W4285593650","https://openalex.org/W3081112627"],"abstract_inverted_index":{"Introduction.":[0],"Interferons":[1],"(IFNs)":[2],"modulate":[3],"the":[4,7,61,114,136,166,178,287,407],"response":[5,241,359],"of":[6,65,126,138,147,161,168,173,180,200,236,262,271,289,333,354,410,414],"immune":[8],"system":[9],"to":[10,347,352,427],"viruses":[11],"and":[12,28,63,67,79,102,107,117,156,184,226,250,264,308,345,377,389,405,422],"decrease":[13],"vascular":[14],"leakage.":[15],"IFNs":[16],"have":[17],"shown":[18],"in-vitro":[19],"activity":[20],"against":[21],"severe":[22,291,348,426],"acute":[23,38],"respiratory":[24,31,39],"syndrome":[25,32,41],"coronavirus":[26,33],"(SARS-CoV)":[27],"Middle":[29],"East":[30],"(MERS-CoV).":[34],"It":[35,46,266,363],"may":[36],"improve":[37],"distress":[40],"(ARDS)":[42],"complications":[43],"in":[44,71,95,252,322,367,369,395,419,425],"COVID-19.":[45,56,74,411,429],"is":[47,416],"currently":[48],"under":[49],"investigation":[50],"as":[51],"a":[52,365],"potential":[53],"treatment":[54],"for":[55,105,260],"Objective.":[57],"This":[58],"review":[59,78],"assessed":[60,176,394],"efficacy":[62,388],"safety":[64,390],"interferon":[66,68,139,141,415],"combination":[69,142],"therapy":[70,143],"patients":[72,208,323],"with":[73,119,145,197,212,234,339,372,399],"Methods.":[75],"A":[76,83],"systematic":[77],"meta-analysis":[80],"were":[81,129,149,189,209,381],"performed.":[82],"search":[84,110],"was":[85,111,163,175],"conducted":[86,112],"from":[87,329],"December":[88],"1,":[89],"2019,":[90],"until":[91],"March":[92],"30,":[93],"2021,":[94],"MEDLINE,":[96],"Cochrane":[97],"CENTRAL,":[98],"clinicaltrials.gov,":[99],"medRxiv,":[100],"ChinaXiv,":[101],"bioRxiv":[103],"databases":[104],"studies":[106],"preprints.":[108],"The":[109,159],"using":[113,165,177,191],"keywords":[115],"\u201cinterferon\u201d":[116],"\u201cCOVID-19\u201d":[118],"no":[120],"restrictions":[121],"on":[122,135,170,242,273,311,360],"language.":[123],"Reference":[124],"lists":[125],"selected":[127],"articles":[128],"also":[130,267],"reviewed.":[131],"Randomized":[132],"controlled":[133,397],"trials":[134,398,421],"use":[137,413,424],"or":[140,213,293,301,337],"compared":[144,233],"standard":[146,235,332,353],"care":[148,355],"included.":[150,210],"Two":[151],"reviewers":[152],"independently":[153],"screened,":[154],"appraised,":[155],"extracted":[157],"data.":[158],"risk":[160],"bias":[162],"appraised":[164],"Evaluation":[167,185],"Articles":[169],"Therapy.":[171],"Certainty":[172],"evidence":[174,201],"Grading":[179],"Recommendation,":[181],"Assessment,":[182],"Development,":[183],"(GRADE)":[186],"approach.":[187],"Data":[188],"analyzed":[190],"RevMan":[192],"5.4.":[193],"Results.":[194],"Three":[195],"RCTs":[196],"low":[198],"certainty":[199],"involving":[202],"4,279":[203],"hospitalized":[204],"COVID":[205],"19":[206],"adult":[207],"IFN-\u03b2":[211,238,325,336],"without":[214,403],"lopinavir":[215,340],"did":[216,283,326,341],"not":[217,284,327,342,382],"significantly":[218,285],"reduce":[219,286,343],"mortality":[220,253,344,368],"(RR":[221],"1.12,":[222],"95%":[223,229,256,278,297,305,316],"CI":[224,230,279,298,306,317],"0.83-1.51":[225],"RR":[227],"1.16,":[228],"0.96-1.39,":[231],"respectively)":[232],"care.":[237,334],"showed":[239,268,357],"clinical":[240,358,420],"day":[243,274,312,361],"14":[244],"(aOR":[245,254],"4.05":[246],"(95%":[247],"CI,":[248],"1.42-11.55)":[249],"reduction":[251,366],"6.65,":[255],"1.67-26.45)":[257],"after":[258],"adjustment":[259],"co-administration":[261],"glucocorticoid":[263],"IVIg.":[265],"increased":[269],"odds":[270,288],"recovery":[272],"16":[275,313],"(OR":[276,295,303,314],"3.19,":[277],"1.24-8.24),":[280],"but":[281,356],"it":[282],"developing":[290],"disease":[292,349],"death":[294,302],"0.28,":[296],"0.07-1.08),":[299],"intubation,":[300],"0.42,":[304],"0.09-1.83)":[307],"hospital":[309],"discharge":[310],"1.63,":[315],"0.61-4.35).":[318],"Serious":[319],"adverse":[320,379],"events":[321,380],"receiving":[324,331],"differ":[328],"those":[330],"Conclusion.":[335],"combined":[338],"progression":[346],"when":[350],"added":[351],"16.":[362],"demonstrated":[364],"one":[370],"study":[371],"small":[373],"sample":[374,401],"size.":[375],"Adverse":[376],"serious":[378],"statistically":[383],"significant":[384],"between":[385],"groups.":[386],"Its":[387],"should":[391],"further":[392],"be":[393],"randomized":[396],"higher":[400],"sizes,":[402],"co-interventions,":[404],"during":[406],"earlier":[408],"stages":[409],"Current":[412],"limited":[417],"only":[418],"compassionate":[423],"critical":[428]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2022-08-27T00:00:00"}